Impact of Systematic Joint Examination (Ultrasound, Functional and Physical) on Treatment Management Decisions in Patients With Haemophilia A in France: Final Data From the Prospective, Observational A‐MOVE Study

• DOI: 10.1111/hae.70012
• Publication Date: 2025-03-11T22:42:53Z
• Authors: Nicolas Drillaud; Virginie Barbay; Jean Baptiste Val...; Romain Jailler; Aurélien Lebreton; Brigitte Pan‐Petesch; Sabine Marie Castet; Birgit Frotscher; Laurent Frenzel; Sandrine Jousse‐J...; Hervé Chambost; Mikaela Alenäs; Markus Fusser; Corinne Gandossi; Meriem Zidi; Oussama Mahdout; Yohann Repessé

ABSTRACTBackgroundHaemophilia management aims to prevent bleeding and preserve joint function. Changes in patients’ joint health may influence physicians' decisions to adjust treatment. The Haemophilia Joint Health Score (HJHS) and Haemophilia Early Arthropathy Detection with Ultrasound (HEAD‐US) score assess joint health but are not routinely used.AimTo evaluate whether systematic joint examination with HJHS and/or HEAD‐US had an impact on treatment management decisions in France, using final data from the A‐MOVE study.MethodsA‐MOVE (NCT04133883) was a 12‐month prospective, multicentre study, which enrolled persons with haemophilia A (all severities, aged 6–40 years) treated prophylactically or on demand with standard/extended half‐life FVIII replacement. At baseline, 6 and 12 months, HJHS/HEAD‐US and changes in patients’ management were assessed.ResultsEighty‐six patients from 20 sites were included in the final analysis; 68 had HJHS/HEAD‐US assessments at 12 months. Over 12 months, 24.4% (n = 21/86) of patients experienced an impact on their haemophilia management due to HJHS/HEAD‐US scores; these decisions were impacted by HJHS in about half of the patients (52.4%, n = 11/21) and HEAD‐US in almost all patients (95.2%, n = 20/21). Both assessments contributed to a change in management decisions in about half of the patients (47.6%, n = 10/21). Twenty‐nine patients (33.7%) had haemophilia management decisions impacted by factors other than HJHS/HEAD‐US, including physical examination findings (n = 9) and the occurrence of bleeding episodes (n = 8).ConclusionsFinal data from the A‐MOVE study show that systematic joint assessments, through functional/physical examination (HJHS) and ultrasound (HEAD‐US), may impact treatment management decisions in persons with haemophilia A.